|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Saturday, April 19
Rituxan Phase II/III Clinical Trial for Primary-Progressive Multiple Sclerosis (PPMS)
by
All About MS
on Sat 19 Apr 2008 10:14 AM CST
Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) today announced that a Phase II/III study of Rituxan® (rituximab) for primary-progressive multiple sclerosis (PPMS) did not meet its primary endpoint as measured by the time to more »
|
||
